Predictive Discovery Limited (ASX: PDI) has locked in a major $69.2 million investment through a strategic private placement with the Lundin Family and Zijin Mining Group. This funding will accelerate…
Gold Hydrogen Secures $6.45M R&D Tax Refund and Strengthens Technical Team
Financial Boost for 2025 Work Program Gold Hydrogen Limited (ASX: GHY) has received a $6.45 million R&D tax refund related to its Natural Hydrogen and Helium exploration activities for the…
Woolworths Announces Leadership Changes and Organisational Restructure
Woolworths Group (ASX: WOW) has unveiled key leadership changes and an organisational restructure aimed at enhancing customer impact and simplifying operations within its food division. Key Leadership Appointments Annette Karantoni…
Westpac Appoints Paul Fowler as Chief Executive, Business & Wealth
Westpac (ASX: WBC) has announced the appointment of Paul Fowler as Chief Executive, Business & Wealth, bringing over 20 years of experience in financial services, corporate finance, and wealth management….
Westgold Revises FY25 Guidance Amid Engineering Ramp-Up Challenges
Westgold Resources (ASX/TSX: WGX) has updated its FY25 production and cost guidance, adjusting expectations due to slower-than-planned ramp-ups at its Beta Hunt and Bluebird-South Junction mines. While the company remains…
Resolute Mining CEO Steps Down, Chris Eger Appointed as Successor
There’s a shake-up at Resolute Mining (ASX/LSE: RSG) as CEO and Managing Director Terry Holohan departs with immediate effect. The company is currently discussing the terms of a proposed settlement…
Telix Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline
Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has wrapped up its acquisition of ImaginAb, Inc., a deal that brings next-generation therapeutic assets, a cutting-edge biologics technology platform, and a research facility…
ResMed Delivers Strong Q2 Results: 10% Revenue Growth & 52% Profit Surge
ResMed (NYSE: RMD, ASX: RMD) has kicked off 2025 on a high note, reporting 10% year-over-year revenue growth and a 52% jump in operating profit for the second quarter of…
Paradigm Teams Up with Advanced Clinical for Pivotal Osteoarthritis Trial
Big news from Paradigm Biopharmaceuticals – they’ve officially chosen Advanced Clinical as their Clinical Research Organisation (CRO) for the upcoming Phase 3 clinical trial (PARA_OA_012). This is a major step…
Origin Energy’s December Quarter: Strong Growth, But a Few Speed Bumps
Origin Energy wrapped up 2024 with a solid quarter, showing strong revenue growth in its gas and energy businesses, while Octopus Energy continued its rapid expansion. But it wasn’t all…